Print

Basilea Pharmaceutica (BSLN.SW) Appoints New Chief Financial Officer  
11/4/2013 9:37:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today the promotion of Mr. Donato Spota to Chief Financial Officer of the Company, effective today. As a member of the management committee, he will be responsible for finance, information technology, and internal services. Mr. Spota has served as Global Head of Finance and Services since February 2013. Prior to this position, Mr. Spota acted as Head of Basilea's Global Controlling since 2002.

Help employers find you! Check out all the jobs and post your resume.

//-->